| Variation | | Type (Consequence) | Condition | Classification, Review status |
|---|
| | RAD51D, RAD51L3-RFFL (M180T +2 more) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | |
| | RAD51D, RAD51L3-RFFL (R266C +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | not provided +6 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (R232* +2 more) | Single nucleotide variant (nonsense +1 more) | Diffuse midline glioma, H3 K27-altered +5 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (splice donor variant) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | GPathogenic/Likely pathogenic |
| | RAD51D, RAD51L3-RFFL (C139fs) | Deletion (frameshift variant +2 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | | Single nucleotide variant (splice donor variant +1 more) | Neoplasm of ovary | |
| | | Single nucleotide variant (synonymous variant +2 more) | Hereditary cancer-predisposing syndrome +2 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (G68S) | Single nucleotide variant (missense variant +1 more) | not provided +4 more | |
| | RAD51D, RAD51L3-RFFL (M1R) | Single nucleotide variant (missense variant +2 more) | not provided +3 more | GConflicting classifications of pathogenicity |
Click to view in NCBI Gene